Synopsis Competitive and technological changes in the pharmaceutical industry-powerful new drug discoveries, innovative R&D partnerships and marketing plans-are changing the business strategies of many pharma companies. But they face the challenge of spiraling cost of drugs, searching for new drugs, patent expirations and cutting medical care costs. The book also takes a look at the changing face of this industry and profiles the operations of several companies internationally. Cases included are Elly Lilly, Glaxo Wellcome, Merck, Pfizer and Ranbaxy.